Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

Multiple Programs Poised to Advance in 2018 DUBLIN , Feb. 27, 2018 /PRNewswire/ — Theravance Biopharma, Inc. (” Theravance Biopharma ” or the “Company”) (NASDAQ: TBPH) today reported financial results for the fourth quarter and full year ended December 31, 2017 .

READ FULL TEXT

Leave a Reply

Your email address will not be published.